Alpha-1-adrenoceptor blocking activity of KT-210 (nipradilol opthalmic solution) on intraocular pressure in the rabbit eye

Folia Ophthalmologica Japonica

Volumn 50, Issue 8, 1999, Pages 655-660

  Nishio, Ken Ichi ^a,c   Kimura, Takahito ^a   Orihashi, Masahiro ^a   Yui, Minoru ^a   Mizuno, Ken ^b  

^a Teika Pharmaceutical Co Ltd   (Japan)

^b KOWA COMPANY LTD   (Japan)

^c Teika Pharmaceutical Co Ltd   (Japan)

Author keywords

Alpha Adrenoceptor Blocking Activity; Beta Adrenoceptor Blocker; Nipradilol; Ocular Hypotensive Effect; Rabbit

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BUNAZOSIN; EYE DROPS; NIPRADILOL; PHENYLEPHRINE; TIMOLOL;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; INTRAOCULAR PRESSURE ABNORMALITY; NONHUMAN; PRESSURE MEASUREMENT; RABBIT;

EID: 0032864132     PISSN: 00155667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Uchida Y, Nakamura M, Shimizu S, Shirasawa Y & Fujii M: Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropyl-amino)propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Arch Int Pharmacodyn Ther 262: 132-149, 1983.
2. Ohira A, Wada Y, Fujii M, Nakamura M, Kasuya Y, Hamada Y & Shigenobu K: Effects of nipradilol (K-351) on alpha-adrenoceptor mediated response in various isolated tissues. Arch Int Pharmacodyn Ther 278: 61-71, 1985.
3. Nakagawa Y, Nakahara H, Chin W & Imai S: α-Blockade and vasodiation induced by nipradilol, arotinolol and labetalol in pithed rats. Jpn J Pharmacol 39: 481-485, 1985.
4. 2-adrenoceptor stimulation on intraocular pressure in the conscious rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 316: 294-298, 1981.
5. Conquest PH & Vareilles P: Effects of ocular hypotensive agents on prostaglandin mediated evaluation of intraocular pressure. Ophthalmic Res 10. 202-211, 1978.
6. Nishimura K, Kuwayama Y, Matsugi T, Sun N & Shirasawa E: Selective suppression by bunazosin of alpha-adrenergic agonist evoked elevation of intraocular pressure in sympathectomized rabbit eyes. Invest Ophthalmol Vis Sci 34: 1761-1766, 1993.
7. Innemee HC & Van Zwieten PA: An increase in intraocular pressure due to clonidine. Graefes Arch Klin Exp Ophthalmol 207: 149-156, 1978.
8. Rowland JM & Potter DE: Adrenergic drugs and intraocular pressure: The hypertensive effects of epinephrine. Opthalmic Res 12: 615-625, 1980.
9. Scriabine A, Torchiana ML, Stavorski JM, Ludden CM, Minsker DH & Stone CA: Some cardiovascular effects of timolol a new β-adrenergic blocking agent. Arch Int Pharmacodyn Ther 205: 76-93, 1973.
10. Gregory DS: Timolol reduces IOP in normal NZW rabbits during the dark only. Invest Ophthalmol Vis Sci 31: 715-721, 1990.
11. Yoshitomi T & Gregory DS: Ocular adrenergic nerves contribute to control of the circadian rhythm of aqueous flow in rabbits. Invest Ophthalmol Vis Sci 32: 523-523, 1991.
12. Shoji T, Daiku Y & Igarashi T: α-Adrenoceptor blocking properties of a new antihypertensive agent, 2-L4-(n-butyryl)-homopiperazin-1-yl]-4-amino-6,7-dimetoxy-quinazoline (E-643). Jpn J Pharmacol 30: 763-772, 1980.